Gabitril
Product Images NDC 16590-832

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabitril (NDC 16590-832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chart 1 (Chart 1)

A line graph comparing the percentage reduction in partial seizure rate versus the percentage of patients for GABITRIL 32 + 56 mg/day and placebo. The vertical axis represents percent reduction in partial seizure rate, with improvement upwards and worsening downwards. The horizontal axis shows percent of patients, with curves indicating greater improvement for GABITRIL compared to placebo.*

FDA Label Image

Chart 2 (Chart 2)

A line graph showing percentage reduction in partial seizure rate versus percentage of patients for GABITRIL at doses of 16 mg/day, 32 mg/day, 56 mg/day, and placebo. The vertical axis represents improvement or worsening, and the horizontal axis represents the percentage of patients. Multiple lines show dose-dependent effects on seizure reduction.*

FDA Label Image

Chart 3 (Chart 3)

A line graph showing the percentage reduction in partial seizure rate on the y-axis against the percentage of patients on the x-axis. The graph compares data for placebo, GABITRIL 8 mg QID, and GABITRIL 16 mg BID, with a vertical arrow indicating improvement above and worsening below a zero percent change line.*

FDA Label Image

Chart 4 (Chart 4)

A line graph comparing the percentage reduction in partial seizure rate versus the percentage of patients for placebo and GABITRIL 10 mg TID. The vertical axis represents improvement or worsening in seizure rate, while the horizontal axis shows the percentage of patients. The graph includes two lines, one dotted for placebo and one solid for GABITRIL, showing effectiveness in reducing seizures.*

FDA Label Image

Label Image (Gabitril 12mg Label)

GABITRIL 12 mg tablets packaging label by STAT RX USA LLC, containing 30 tablets. The label identifies it as a generic for Tiagabine Hcl 12 mg, with storage instructions and warnings about potential drowsiness or dizziness. It includes manufacturer information for Cephalon Inc., batch and lot details, along with safety instructions to keep out of reach of children.*

FDA Label Image

Logo (Gabitril Logo)

FDA Label Image

Structure Image (Gabitril Structure)

Chemical structure of the active ingredient of GABITRIL by STAT RX USA LLC, labeled with product NDC 16590-832. The diagram depicts the molecular arrangement, including two thiophene rings, a piperidine ring, and various functional groups, along with a hydrochloride (HCl) moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.